Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294060 · ClinicalTrials.gov registry record
P3: Pacemaker Patient Profiling Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 2,013
- Enrollment target
NCT00294060 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 2,013 participants.
The verdict
NCT00294060 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 2,013 participants
- Enrollment target
Study Summary
The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,013 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294060
The ClinicalTrials.gov registry entry for NCT00294060 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2,013 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00294060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294060 about?
NCT00294060 is a clinical study titled "P3: Pacemaker Patient Profiling Study". The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.
What is the current status of trial NCT00294060?
This trial is currently terminated. The enrollment target is 2,013 participants. The study started on 2004-03. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00294060?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.